You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be great ...

If you want to get shredded, take it from one of the top bodybuilders since Arnold Schwarzenegger: Heavy weights and plenty of protein are the simple rules for success. Chris Bumstead has dominated ...

Share on Pinterest New research suggests that eating more protein while taking GLP-1 drugs could help prevent muscle loss. Stocksy United Increasing protein intake while taking GLP-1 drugs for weight ...

A new study suggests that Eli Lilly’s GLP-1 drug tirzepatide, marketed as Zepbound and Mounjaro, leads to greater overall ...

Incretin-based obesity medications may result in higher muscle-related loss vs. other weight loss strategies, according to data published in Annals of Internal Medicine.The findings “suggest that ...

A phase 2 clinical trial found that combining semaglutide with the antibody bimagrumab led to greater weight loss and better preservation of lean muscle than semaglutide alone. Bimagrumab appears to ...

Millions of people in the United States have type 2 diabetes and/or obesity. Many of the drugs that treat these often cause people to lose muscle mass. Muscle mass loss can cause a loss of strength ...

For a little over a century, modern weight loss medications have worked to provide a slimming solution that mature adults can count on. Subsequently, reduction drugs such as glucagon-like peptide-1 ...

GLP-1 agonist medications (Ozempic and Wegovy) and dual GIP/GLP-1 receptor agonist medications (Zepbound and Mounjoaro) are powerful tools for weight loss, but losing weight rapidly can also lead the ...

In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type ...

View post: ‘Smart Fabric’ Turns Sweat Into Real-Time Health Data View post: One of Bulova's 'Bold and Handsome' Dive Watches Is Over 40% Off on Amazon Right Now You don’t have to pick between losing ...

A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again.